BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

BATS BZX Real-Time Price
As of 11:58am ET
 -0.105 / -0.85%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for BioCryst Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 30.00 and a low estimate of 14.00. The median estimate represents a +30.51% increase from the last price of 12.26.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Hold stock in BioCryst Pharmaceuticals Inc. This rating has held steady since August, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 15.63%
Growthannually -19.66%


Growthquarterly 15.68%
Growthannually 74.47%
Key to the earnings and sales forecast charts.